<div class="container">

<table style="width: 100%;"><tr>
<td>ssri</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Studies of Selective Serotonin Reuptake Inhibitors (SSRIs) for major depression</h2>

<h3>Description</h3>

<p>A dataset from a systematic review examining the efficacy of different doses of SSRI antidepressant drugs and placebo
(Furukawa et al. 2019). The response to treatment is defined as a 50% reduction in depressive symptoms after 8 weeks
(4-12 week range) follow-up. The dataset includes 60 RCTs comparing 5 different SSRIs with placebo.
</p>


<h3>Usage</h3>

<pre><code class="language-R">ssri
</code></pre>


<h3>Format</h3>

<p>A data frame in long format (one row per arm and study), with 145 rows and 8 variables:
</p>

<ul>
<li> <p><code>studyID</code> Study identifiers
</p>
</li>
<li> <p><code>bias</code> Risk of bias evaluated on 6 domains
</p>
</li>
<li> <p><code>age</code> Mean participant age
</p>
</li>
<li> <p><code>weeks</code> Duration of study follow-up
</p>
</li>
<li> <p><code>agent</code> Character data indicating the agent to which participants were randomised
</p>
</li>
<li> <p><code>dose</code> Numeric data indicating the dose to which participants were randomised in mg
</p>
</li>
<li> <p><code>n</code> Numeric data indicating the number of participants randomised
</p>
</li>
<li> <p><code>r</code> Numeric data indicating the number of participants who achieved &gt;50% improvement in depression symptoms
</p>
</li>
</ul>
<h3>References</h3>

<p>Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G (2019).
“Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.”
<em>Lancet Psychiatry</em>, <b>6</b>, 601-609.
</p>


</div>